UBS Group’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.56M Sell
187,887
-19,402
-9% -$836K ﹤0.01% 3639
2025
Q4
$10.5M Buy
207,289
+45,214
+28% +$1.61M ﹤0.01% 3231
2025
Q3
$4.71M Buy
162,075
+59,142
+57% +$1.37M ﹤0.01% 4103
2025
Q2
$2.43M Sell
102,933
-356,734
-78% -$8.02M ﹤0.01% 4615
2025
Q1
$11M Buy
459,667
+362,364
+372% +$11.6M ﹤0.01% 2930
2024
Q4
$4.11M Buy
97,303
+14,929
+18% +$661K ﹤0.01% 4042
2024
Q3
$3.64M Buy
82,374
+7,912
+11% +$300K ﹤0.01% 3391
2024
Q2
$2.69M Sell
74,462
-51,921
-41% -$2.06M ﹤0.01% 3453
2024
Q1
$5.45M Buy
126,383
+10,961
+9% +$391K ﹤0.01% 2884
2023
Q4
$1.78M Buy
115,422
+71,487
+163% +$908K ﹤0.01% 3959
2023
Q3
$602K Buy
43,935
+23,202
+112% +$398K ﹤0.01% 4514
2023
Q2
$333K Buy
20,733
+11,800
+132% +$107K ﹤0.01% 5146
2023
Q1
$69.3K Buy
8,933
+8,036
+896% +$62K ﹤0.01% 6184
2022
Q4
$17.4K Sell
897
-4,401
-83% -$79.7K ﹤0.01% 7840
2022
Q3
$113K Buy
5,298
+4,903
+1,241% +$91.8K ﹤0.01% 5609
2022
Q2
$5K Sell
395
-1,614
-80% -$28.2K ﹤0.01% 8942
2022
Q1
$47K Buy
+2,009
New +$43.2K ﹤0.01% 6565
2021
Q3
Sell
-956
Closed -$13K 10122
2021
Q2
$13K Buy
+956
New +$14.9K ﹤0.01% 7810

Other funds holding VERA